Dynatronics (NASDAQ:DYNT) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.
According to Zacks, “DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners. “
Dynatronics (DYNT) opened at $3.15 on Friday. The company has a current ratio of 1.46, a quick ratio of 0.92 and a debt-to-equity ratio of 0.81. Dynatronics has a 52-week low of $2.10 and a 52-week high of $3.75.
Dynatronics (NASDAQ:DYNT) last issued its quarterly earnings data on Tuesday, November 14th. The medical equipment provider reported $0.00 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.08) by $0.08. The business had revenue of $12.80 million during the quarter. Dynatronics had a negative return on equity of 45.78% and a negative net margin of 3.42%. research analysts predict that Dynatronics will post -0.09 earnings per share for the current fiscal year.
In other Dynatronics news, major shareholder Stuart Essig acquired 27,455 shares of Dynatronics stock in a transaction dated Wednesday, January 3rd. The stock was acquired at an average cost of $2.77 per share, for a total transaction of $76,050.35. Following the completion of the transaction, the insider now owns 856,169 shares in the company, valued at approximately $2,371,588.13. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Brian Larkin acquired 40,000 shares of Dynatronics stock in a transaction dated Thursday, November 30th. The shares were acquired at an average price of $2.50 per share, with a total value of $100,000.00. Following the completion of the transaction, the director now owns 80,276 shares of the company’s stock, valued at approximately $200,690. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 369,015 shares of company stock valued at $930,372. Insiders own 51.80% of the company’s stock.
An institutional investor recently bought a new position in Dynatronics stock. First Light Asset Management LLC acquired a new position in shares of Dynatronics Co. (NASDAQ:DYNT) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 100,000 shares of the medical equipment provider’s stock, valued at approximately $280,000. First Light Asset Management LLC owned 2.72% of Dynatronics at the end of the most recent quarter. Institutional investors and hedge funds own 18.17% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Zacks Investment Research Downgrades Dynatronics (DYNT) to Hold” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/14/zacks-investment-research-downgrades-dynatronics-dynt-to-hold.html.
Dynatronics Company Profile
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.